Show simple item record

dc.contributor.authorMcKetin, Rebecca
dc.date.accessioned2018-05-18T07:57:08Z
dc.date.available2018-05-18T07:57:08Z
dc.date.created2018-05-18T00:23:28Z
dc.date.issued2018
dc.identifier.citationMcKetin, R. 2018. Methamphetamine psychosis: Insights from the past. Addiction. 113 (8): pp. 1522-1527.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/67080
dc.identifier.doi10.1111/add.14170
dc.description.abstract

Background and aims: To review early case reports and experimental inductions of amphetamine and methamphetamine psychosis, prior to the prohibition of these drugs, to gain a better understanding of the nature and aetiology of methamphetamine psychosis. Methods: Papers considered were historical case reports and case series of psychosis relating to the use and misuse of prescription amphetamine, focusing upon papers by Young & Scoville (1938), Connell (1958), and three subsequent experimental studies published in the early 1970s (Griffith 1972, Angrist & Gershon 1970 and Bell 1973), where psychosis was induced in volunteers using high-dose amphetamine and methamphetamine. Results: High-dose methamphetamine and amphetamine can result in a paranoid psychosis which remits rapidly (within days) of discontinuing use. The central feature is paranoia occurring in a clear state of consciousness. This may be accompanied by other psychotic symptoms (e.g. hallucinations). Pre-existing schizophrenia is not necessary, and the syndrome is not due to sleep deprivation. Conclusions: Research findings from the 1930s to the 1970s suggest that paranoid psychosis should be considered a probable consequence of high-dose methamphetamine use. Individuals who experience psychotic symptoms for any substantive period after intoxication has ended should be suspected of having a functional non-organic psychosis, or a latent vulnerability thereto.

dc.publisherWiley-Blackwell Publishing Ltd.
dc.titleMethamphetamine psychosis: Insights from the past
dc.typeJournal Article
dcterms.source.issn0965-2140
dcterms.source.titleAddiction
curtin.departmentNational Drug Research Institute (NDRI)
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record